July 9 (Reuters) - The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's (LLY.N), opens new tab Alzheimer's drug Kisunla to allow more gradual dosing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback